In particular, participants in the fourth FSH were more likely to have renal dysfunction, which was in agreement with the results of the previous study that higher FSH was an independent risk factor declined eGFR and CKD in postmenopausal women (5). The gene discussed is BRD2; the disease is Abnormal renal physiology.